Literature DB >> 8387024

Trapping an intermediate form of connexin43 in the Golgi.

K L Puranam1, D W Laird, J P Revel.   

Abstract

We have used the metabolic inhibitor monensin to study the biosynthesis and translocation of connexin43 (Cx43) gap junction protein in rat cardiac myocytes. Immunocytochemical labeling of monensin-treated cells show that Cx43 enters and accumulates in the Golgi apparatus. Immunoprecipitation of Cx43 from monensin-treated cells results in the isolation of 40- and 41-kDa forms of the protein. Our results demonstrate that the 41-kDa form of Cx43 is sensitive to alkaline phosphatase, suggesting that it represents a phosphorylated state of the nascent 40-kDa form of Cx43. These results further suggest that Cx43 is initially phosphorylated early in the secretory pathway. It is likely that more extensive phosphorylation of Cx43 to the higher forms (42 and 44 kDa) occur at locations distal to the site of monensin blockage in the Golgi.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387024     DOI: 10.1006/excr.1993.1123

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

Review 1.  The connexin turnover, an important modulating factor of the level of cell-to-cell junctional communication: comparison with other integral membrane proteins.

Authors:  Jean-Claude Hervé; Mickaël Derangeon; Bouchaib Bahbouhi; Marc Mesnil; Denis Sarrouilhe
Journal:  J Membr Biol       Date:  2007-08-01       Impact factor: 1.843

Review 2.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

Review 3.  The life cycle of a connexin: gap junction formation, removal, and degradation.

Authors:  D W Laird
Journal:  J Bioenerg Biomembr       Date:  1996-08       Impact factor: 2.945

Review 4.  Posttranslational modifications in connexins and pannexins.

Authors:  Scott R Johnstone; Marie Billaud; Alexander W Lohman; Evan P Taddeo; Brant E Isakson
Journal:  J Membr Biol       Date:  2012-06-28       Impact factor: 1.843

5.  Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of connexin43.

Authors:  R C Burghardt; R Barhoumi; T C Sewall; J A Bowen
Journal:  J Membr Biol       Date:  1995-12       Impact factor: 1.843

Review 6.  Adrenergic control of cardiac gap junction function and expression.

Authors:  Aida Salameh; Stefan Dhein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-12       Impact factor: 3.000

Review 7.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

8.  The C-terminus of connexin43 adopts different conformations in the Golgi and gap junction as detected with structure-specific antibodies.

Authors:  Gina E Sosinsky; Joell L Solan; Guido M Gaietta; Lucy Ngan; Grace J Lee; Mason R Mackey; Paul D Lampe
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

9.  Analyzing phorbol ester effects on gap junctional communication: a dramatic inhibition of assembly.

Authors:  P D Lampe
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

10.  Gap junction turnover, intracellular trafficking, and phosphorylation of connexin43 in brefeldin A-treated rat mammary tumor cells.

Authors:  D W Laird; M Castillo; L Kasprzak
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.